| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 08/22/2012 | CN101812084B Rare earth metal amine compound containing aromatic amine methylene pyrrole ligand, preparation method and application thereof |
| 08/21/2012 | US8247562 Benzamide derivatives useful as histone deacetylase inhibitors |
| 08/21/2012 | US8247551 Lead sensor and methods of use |
| 08/21/2012 | US8247550 Certain substituted amides, method of making, and method of use thereof |
| 08/21/2012 | CA2545427C Selective kinase inhibitors |
| 08/16/2012 | WO2012109256A2 Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine |
| 08/16/2012 | WO2012071414A3 Quinoxaline compounds and uses thereof |
| 08/16/2012 | US20120208896 Amino acid derivatives and absorable polymers therefrom |
| 08/16/2012 | CA2826973A1 Formation of n-protected bis-3,6-(4-aminoalkyl)-2,5,diketopiperazine |
| 08/15/2012 | EP2486014A1 Modulators of g protein-coupled receptor 88 |
| 08/15/2012 | EP2485731A1 Heterocyclic compounds useful as pdk1 inhibitors |
| 08/15/2012 | CN102639496A Lysine specific demethylase-1 inhibitors and their use |
| 08/15/2012 | CN102634333A High-sensitive-polarity fluorescent probe by taking acenaphtho-pyrazine as mother body and preparation method and application thereof |
| 08/15/2012 | CN102633732A Phthalazine-like derivative and application thereof |
| 08/15/2012 | CN102633731A 6-quinoxaline formic acid amide compounds, preparation method and application thereof |
| 08/15/2012 | CN102633730A Substituted piperazines as cb1 antagonists |
| 08/15/2012 | CN102633716A Bicyclic inhibitors of mek and methods of use thereof |
| 08/15/2012 | CN101678020B Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases |
| 08/14/2012 | US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/14/2012 | CA2449836C Stereoselective preparation of cyclic l-amino acids |
| 08/09/2012 | WO2012104659A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease |
| 08/09/2012 | WO2012104415A1 A thionation process and a thionating agent |
| 08/09/2012 | WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof |
| 08/09/2012 | US20120202794 Compounds |
| 08/09/2012 | US20120201763 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 08/09/2012 | CA2825257A1 A thionation process and a thionating agent |
| 08/08/2012 | EP2484655A1 A thionation process and a thionating agent |
| 08/08/2012 | EP2035004B1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 08/08/2012 | CN101384604B Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 08/07/2012 | US8236808 Pyrazine derivatives as ENAC blockers |
| 08/07/2012 | US8236801 2-aza-bicyclo[2.2.1]heptane derivatives |
| 08/07/2012 | CA2543249C Phenyl derivatives as ppar agonists |
| 08/02/2012 | WO2012103113A1 Pyrazine and imidazolidine derivatives and their uses to treat hepatitis c |
| 08/02/2012 | WO2012063085A3 Drug derivatives |
| 08/02/2012 | US20120197020 Heterocyclic compound |
| 08/02/2012 | US20120197005 Containerless synthesis of amorphous and nanophase organic materials |
| 08/01/2012 | EP2480528A1 Lysine specific demethylase-1 inhibitors and their use |
| 08/01/2012 | EP2155201B1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 08/01/2012 | EP1871749B1 Selurampanel |
| 08/01/2012 | CN102617493A Mequindox artificial antigens and antibodies prepared by same |
| 08/01/2012 | CN102617492A Process for synthesizing Janus green B |
| 08/01/2012 | CN102617491A 3-oxo-3,4-dihydro-2-pyrazinecarboxamide derivative, medicinal composition thereof and preparation method and application of 3-oxo-3,4-dihydro-2-pyrazinecarboxamide derivative |
| 08/01/2012 | CN102617490A Process for preparing pyrazine-2-formic acid through metalloporphyrin catalytic oxidation of 2-methylpyrazine |
| 08/01/2012 | CN102617489A Preparation method of sulfaclozine sodium |
| 08/01/2012 | CN102198137B Application of ligustrazine derivant in preparing medicine for treating hepatic fibrosis |
| 07/31/2012 | US8232277 Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use |
| 07/31/2012 | US8231984 Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same |
| 07/26/2012 | US20120190693 Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof |
| 07/26/2012 | US20120190686 Bicyclo[3.2.1]octyl amide derivatives and uses of same |
| 07/26/2012 | US20120189546 Radiolabelling Method Using Cycloalkyl Groups |
| 07/25/2012 | EP2479282A1 Media including nitroreductase enzymatic substrates |
| 07/25/2012 | CN102603658A Preparation method of 6-fluorine-3-hydroxyl-2-pyrazinamide |
| 07/25/2012 | CN102603657A Preparation method of 6-bromine-3-hydroxyl-2-pyrazinamide |
| 07/25/2012 | CN102603655A Synthetic method of deuterium-marked sulfanilamide |
| 07/25/2012 | CN102603552A Preparation method of alpha-keto amide |
| 07/25/2012 | CN102010378B Preparation method of quizalofop-p-ethyl |
| 07/24/2012 | US8227600 Organometallic complex, and light-emitting element and light-emitting device using the same |
| 07/24/2012 | US8227474 Sodium channel blockers |
| 07/24/2012 | US8227409 Diketopiperazine microparticles with defined isomer contents |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/19/2012 | WO2012096556A1 Quinoxaline derivatives which are selective against trypanosoma cruzi and do not cause mutagenic effects |
| 07/18/2012 | EP2476671A1 1H-Quinazoline-2,4-diones |
| 07/18/2012 | EP2475649A1 Indenone derivative and pharmaceutical composition comprising same |
| 07/18/2012 | EP2475643A1 Novel ethane diamine hepcidin antagonists |
| 07/18/2012 | CN102596966A Phthalocyanine compound, preparation method therefor, and coloring composition including said phthalocyanine compound |
| 07/18/2012 | CN102596935A Compounds useful for treating premature aging and in particular progeria |
| 07/18/2012 | CN102596921A Novel compounds |
| 07/18/2012 | CN102584724A Preparation method for quizalofop-p-ethyl |
| 07/18/2012 | CN102584723A Method for synthetizing 2,6-dichloroquinoxaline by using diketene |
| 07/18/2012 | CN102584722A Efficient and environmentally-friendly method for preparing 6-chloro-2-quinoxaline phenol |
| 07/18/2012 | CN101296914B Derivative having PPAR agonistic activity |
| 07/12/2012 | WO2012093862A2 Phenazine-based compound and organic electroluminescent device including same |
| 07/12/2012 | WO2012093165A1 Method for resolution of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan, 1-yl)-3,3-dimethyl-piperazine |
| 07/12/2012 | US20120178935 Catalysis of Diketopiperazine Synthesis |
| 07/12/2012 | US20120178765 Novel glucokinase activators and processes for the preparation thereof |
| 07/12/2012 | US20120178756 Compounds useful as inhibitors of atr kinase |
| 07/12/2012 | CA2823103A1 Method for resolution of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine |
| 07/11/2012 | EP2473488A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 07/11/2012 | CN102575155A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/11/2012 | CN102574843A Fused ring analogues of anti-fibrotic agents |
| 07/11/2012 | CN102574835A Compounds useful for treating cancer |
| 07/11/2012 | CN102574818A Apaf-1 inhibitor compounds |
| 07/11/2012 | CN102574811A Diamine compound, polyamic acid, polyimide, and liquid crystal aligning agent |
| 07/11/2012 | CN102574778A Novel biphenyl and phenyl-pyridine amides |
| 07/11/2012 | CN102558236A Organometallic complex, and light-emitting element and display device using the organometallic complex |
| 07/11/2012 | CN102558076A 1-oxygen-2-hydroxylmethyl-3-(1-ethoxyl)-quinoxaline, as well as preparation method and application of 1-oxygen-2-hydroxylmethyl-3-(1-ethoxyl)-quinoxaline |
| 07/11/2012 | CN102558075A Substituted piperazines as CB1 antagonists |
| 07/11/2012 | CN102558074A Piperazine amide compound containing pyridazine substituent group |
| 07/11/2012 | CN102558065A Heterocyclic bridged biphenyls |
| 07/11/2012 | CN102557135A Nanometer chromium vanadate as well as preparation method and application thereof |
| 07/11/2012 | CN101712646B Alkoxyamines containing a radically polymerizable group |
| 07/10/2012 | US8217063 Lactam-substituted dicarboxylic acids and use thereof |
| 07/10/2012 | US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/10/2012 | US8217047 Therapeutic methods and compounds |
| 07/10/2012 | CA2658334C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 07/05/2012 | WO2012091625A1 N,ν'-substituted piperazines having combined antiaggregant, anticoagulant and vasodilatory activity, and method for producing same |
| 07/05/2012 | WO2012064744A3 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases |
| 07/05/2012 | US20120172349 Therapeutic compounds and compositions |
| 07/04/2012 | EP2471944A1 Novel peptidase substrates |
| 07/04/2012 | CN1791592B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions |